Insights into HIV-1 Reverse Transcriptase (RT) Inhibition and Drug Resistance from Thirty Years of Structural Studies

類似資料

• Approved HIV reverse transcriptase inhibitors in the past decade
  著者:: Guangdi Li, 等
  出版事項: (2022-04-01)
• Mathematical Modelling of the Molecular Mechanisms of Interaction of Tenofovir with Emtricitabine against HIV
  著者:: Sara Iannuzzi, 等
  出版事項: (2021-07-01)
• Development of HIV Drug Resistance in a Cohort of Adults on First-Line Antiretroviral Therapy in Tanzania during the Stavudine Era
  著者:: Raphael Z. Sangeda, 等
  出版事項: (2021-11-01)
• Efficacy and safety of novel russian non-nucleoside reverse transcriptase inhibitor elsulfavirine in combination with 2 nucleoside/nucleotide reverse transcriptase inhibitors in first-line HIV treatment – 96-week study
  著者:: A. V. Kravchenko, 等
  出版事項: (2018-07-01)
• APOBEC3 selects V179I in HIV-1 reverse transcriptase to provide selective advantage for non-nucleoside reverse transcriptase inhibitor-resistant mutants
  著者:: Richa Dwivedi, 等
  出版事項: (2022-07-01)